---
figid: PMC10780524__nutrients-16-00061-g001
pmcid: PMC10780524
image_filename: PMC10780524__nutrients-16-00061-g001.jpg
figure_link: /pmc/articles/PMC10780524/figure/F1/
number: Figure 1
figure_title: 3D Printing of Dietary Products for the Management of Inborn Errors
  of Intermediary Metabolism in Pediatric Populations
caption: 'Schematic representation of an enzymatic metabolic pathway alongside established
  and emerging treatments for Inherited Metabolic Disorders: (a) Substrate Reduction
  Therapy (SRT); (b) Dietary Restriction; (c) Scavenger Therapy; (d) Cofactor Supplementation;
  (e) Enzyme Replacement Therapy, Gene Therapy and Liver Transplantation; (f) Product
  Supplementation; and (g) Dietary Supplementation'
article_title: 3D Printing of Dietary Products for the Management of Inborn Errors
  of Intermediary Metabolism in Pediatric Populations
citation: Paola Carou-Senra, et al. Nutrients. 2024 Jan;16(1).
year: '2024'
pub_date: 2024-1-
epub_date: '2023-12-25'
doi: 10.3390/nu16010061
journal_title: Nutrients
journa_nlm_ta: Nutrients
publisher_name: MDPI
keywords:
- chewable formulations and oral drug products
- dietary therapy and supplements
- intermediary metabolic diseases
- extrusion-based three-dimensional printing of personalized pharma-inks
- pediatric patients
- direct ink writing 3D-printed drug delivery systems
- on-demand dispensing of pharmaceuticals and medicines
---
